BD Life Sciences
United States of America (USA)
1 December 2019 - 30 November 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for BD Life Sciences published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
1 | 0.09 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 1 | 0.09 |
Top articles by Altmetric score in current window
Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function
Science Advances
2020-04-01
1 December 2019 - 30 November 2020
International vs. domestic collaboration by Share
- 88.36% Domestic
- 11.64% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (6 total)
- BD Life Sciences, United States of America (USA)
- Domestic institution
-
Harvard University, United States of America (USA)
(0.95)
-
Center for Molecular Imaging Research (CMIR), United States of America (USA)
(0.14)
-
Broad Institute of MIT and Harvard, United States of America (USA)
(0.12)
-
Massachusetts Institute of Technology (MIT), United States of America (USA)
(0.12)
-
Harvard Stem Cell Institute (HSCI), United States of America (USA)
(0.09)
-
Partners HealthCare, United States of America (USA)
(0.09)
Top 10 international collaborators by Share (2 total)
- BD Life Sciences, United States of America (USA)
- Foreign institution
-
Sanofi, France
(0.11)
-
Siemens AG, Germany
(0.09)
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.